Gene therapy using hematopoietic stem cells: Sisyphus approaches the crest

Human Gene Therapy

Volumn 11, Issue 9, 2000, Pages 1259-1267

  Halene, Stephanie ^a   Kohn, Donald B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; MARKER GENE; NONHUMAN; REVIEW; RNA TRANSLATION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD34; CLINICAL TRIALS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE; MICE; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0034631356     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050032366     Document Type: Review

References (97)

1. AGARWAL, M., AUSTIN, T.W., MOREL, F., CHEN, J., BÖHNLEIN, E., and PLAVEC, I. (1998). Scaffold attachment region-mediated enhancement of retroviral vector expression in primary cells. J. Virol. 72, 3720-3728.
2. BECKER, K.G., JEDLICKA, P., TEMPLETON, N.S., LIOTTA, L., and OZATO, K. (1994). Characterization of hUCRBP (YY1,NF-E1, d): A transcription factor that binds to the regulatory regions of many viral and cellular genes. Gene 150, 259-266.
3. + marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81, 951-955.
4. BJÖRGVINSDÓTTIR, H., DING, C., PECH, N., GIFFORD, M.A., LI, L.L., and DINAUER, M.C. (1997). Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood 89, 41-48.
5. BLÖMER, U., NALDINI, L., KAFRI, T., TRONO, D., VERMA, I.M., and GAGE, F.H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
6. BODINE, D.M., KARLSSON, S., and NIENHUIS, A.W. (1989). Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 86, 8897-8901.
7. BODINE, D.M., McDONAGH, K.T., BRANDT, S.J., NEY, P.A., AGRICOLA, B., BYRNE, E., and NIENHUIS, A.W. (1990). Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3738-3742.
8. BRENNER, M. (1998). Use of gene marking technologies in oncology. Forum (Genova) 8, 342-353.
9. BUNTING, K.D., SANGSTER, M.Y., IHLE, J.N., and SORRENTINO, B.P. (1998). Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nature Med. 4, 58-64. [See comments]
10. BUNTING, K.D., FLYNN, K.J., RIBERDY, J.M., DOHERTY, P.C., and SORRENTINO, B.P. (1999). Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency. Proc. Natl. Acad. Sci. U.S.A. 96, 232-237.
11. CASE, S.S., PRICE, M.A., JORDAN, C.T., YU, X.J., WANG, L., BAUER, G., HAAS, D.L., XU, D., STRIPECKE, R., NALDINI, L., KOHN, D.B., and CROOKS, G.M. (1999). Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 96, 2988-2993.
12. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT-BASILE, G., GORSS, F., NUSBAUM, P., YVON, E., CASANOVA, J.L., LE DEIST, F., and FISCHER, A. (1999). Correction of SCID-X1 disease phenotype following γc gene transfer by a retroviral vector into CD34+ cells in two children. Blood 94(Suppl. 1), 367a.
13. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 2567-2571.
14. CHALLITA, P.M., SKELTON, D., EL-KHOUEIRY, A., YU, X.J., WEINBERG, K., and KOHN, D.B. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
15. CHATTERJEE, S., LI, W., WONG, C.A., FISHER-ADAMS, G., LU, D., GUHA, M., MACER, J.A., FORMAN, S.J., and WONG, K.K., JR. (1999). Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93, 1882-1894.
16. CHEN, L., PULSIPHER, M., CHEN, D., SIEFF, C., ELIAS, A., FINE, H.A., and KUFE, D.W. (1996). Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J. Clin. Invest. 98, 2539-2548.
17. CHENG, L., DU, C., LAVAU, C., CHEN, S., TONG, J., CHEN, B.P., SCOLLAY, R., HAWLEY, R.G., and HILL, B. (1998). Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood 92, 83-92.
18. CROOKS, G.M., and KOHN, D.B. (1993). Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 82, 3290-3297.
19. DAO, M.A., and NOLTA, J.A. (1998). Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction. Int. J. Mol. Med. 1, 257-264. [Review]
20. DAO, M.A., HANNUM, C.H., KOHN, D.B., and NOLTA, J.A. (1997). FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89, 446-456.
21. DAO, M.A., HASHINO, K., KATO, I., and NOLTA, J.A. (1998a). Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 92, 4612-4621.
22. DAO, M.A., TAYLOR, N., and NOLTA, J.A. (1998b). Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 95, 13006-13011.
23. DULL, T., ZUFFEREY, R., KELLY, M., MANDEL, R.J., NGUYEN, M., TRONO, D., and NALDINI, L. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
24. DUNBAR, C.E., SEIDEL, N.E., DOREN, S., SELLERS, S., CLINE, A.P., METZGER, M.E., AGRICOLA, B.A., DONAHUE, R.E., and BODINE, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
25. DZIERZAK, E.A., PAPAYANNOPOULOU, T., and MULLIGAN, R.C. (1998). Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature (London) 331, 35-41.
26. ECKERT, H.G., STOCKSCHLÄDER, M., JUST, U., HEGEWISCH-BECKER, S., GREZ, M., UHDE, A., ZANDER, A., OSTERTAG, W., and BAUM, C. (1996). High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 88, 3407-3415.
27. EMERMAN, M., and TEMIN, H.M. (1986). Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res. 14, 9381-9396.
28. EMERY, D.W., and STAMATOYANNOPOULOS, G. (1999). Stem cell gene therapy for the beta-chain hemoglobinopathie s: Problems and progress. Ann. N.Y. Acad. Sci. 872, 94-107. [Dicussion on pp. 107-108]
29. EMI, N., FRIEDMANN, T., and YEE, J.K. (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65, 1202-1207.
30. FLANAGAN, J.R., BECKER, K.G., ENNIST, D.L., GLEASON, S.L., DRIGGERS, P.H., LEVI, B.Z., APPELLA, E., and OZATO, K. (1992). Cloning of a transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol. Cell. Biol. 12, 38-44.
31. GARCIA-SANCHEZ, F., PIZZORNO, G., FU, S.Q., NANAKORN, T., KRAUSE, D.S., LIANG, J., ADAMS, E., LEFFERT, J.J., YIN, L.H., COOPERBERG, M.R., HANANIA, E., WANG, W.L., WON, J.H., PENG, X.Y., COTE, R., BROWN, R., BURTNESS, B., GILES, R., CRYSTAL, R., and DEISSEROTH, A.B. (1998). Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation. Blood 92, 672-682.
32. GOODELL, M.A., BROSE, K., PARADIS, G., CONNER, A.S., and MULLIGAN, R.C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806.
33. GOODELL, M.A., ROSENZWEIG, M., KIM, H., MARKS, D.F., DEMARIA, M., PARADIS, G., GRUPP, S.A., SIEFF, C.A., MULLIGAN, R.C., and JOHNSON, R.P. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigens exist in multiple species. Nature Med. 3, 1337-1345.
34. GRANDE, A., PIOVANI, B., AIUTI, A., OTTOLENGHI, S., MAVILIO, F., and FERRARI, G. (1999). Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Blood 93, 3276-3285.
35. GREZ, M., AKGÜN, E., HILBERG, F., and OSTERTAG, W. (1990). Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 87, 9202-9206.
36. GRIMM, D., and KLEINSCHMIDT, J.A. (1999). Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use. Hum. Gene Ther. 10, 2445-2450.
37. HALENE, S., WANG, L., COOPER, R.M., BOCKSTOCE, D., ROBBINS, P.B., and KOHN, D.B. (1999). Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 94, 3349-3357.
38. HANENBERG, H., XIAO, X.L., DILLOO, D., HASHINO, K., KATO, I., and WILLIAMS, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 2, 876-882.
39. HANTZOPOULOS, P.A., SULLENGER, B.A., UNGERS, G., and GILBOA, E. (1989). Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. U.S.A. 86, 3519-3523.
40. HENNEMANN, B., CONNEALLY, E., PAWLIUK, R., LEBOULCH, R., ROSE-JOHN, S., REID, D., CHUO, J.Y., HUMPHRIES, R.K., and EAVES, C.J. (1999). Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Exp. Hematol. 27, 817-825.
41. HERZOG, R.W., YANG, E.Y., COUTO, L.B., HAGSTROM, J.N., ELWELL, D., FIELDS, P.A., BURTON, M., BELLINGER, D.A., READ, M.S., BRINKHOUS, K.M., PODSAKOFF, G.M., NICHOLS, T.C., KURTZMAN, G.J., and HIGH, K.A. (1999). Long-term correction of canine hemophilia B by gene transfer of blood co-agulation factor IX mediated by adeno-associated viral vector. Nature Med. 5, 56-63. [See comments]
42. HITT, M.M., ADDISON, C.L., and GRAHAM, F.L. (1997). Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40, 137-206.
43. JACKSON, K.A., MI, T., and GOODELL, M.A. (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 96, 14482-14486.
44. KARLSSON, S., PAPAYANNOPOULOU, T., SCHWEIGER, S.G., STAMATOYANNOPOULOS, G., and NIENHUIS, A.W. (1987). Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc. Natl. Acad. Sci. U.S.A. 84, 2411-2415.
45. KIEM, H.P., ANDREWS, R.G., MORRIS, J., PETERSON, L., HEYWARD, S., ALLEN, J.M., RASKO, J.E., POTTER, J., and MILLER, A.D. (1998). Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92, 1878-1886.
46. KIEM, H.P., HEYWARD, S., WINKLER, A., POTTER, J., ALLEN, J.M., MILLER, A.D., and ANDREWS, R.G. (1997). Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90, 4638-4645.
47. KOHN, D.B., NOLTA, J.A., and CROOKS, J.A. (1998a). Clinical trials of gene therapy using hematopoietic stem cells. In Hematopoietic Cell Transplantation, 2nd Ed. S.J. Forman, K.G. Blume, and E.D. Thomas, eds. (Blackwell Scientific Publications, Boston MA).
48. KOHN, D.B., HERSHFIELD, M.S., CARBONARO, D., SHIGEOKA, A., BROOKS, J., SMOGORZEWSKA, E.M., BARSKY, L.W., CHAN, R., BUROTTO, F., ANNETT, G., NOLTA, J.A., CROOKS, G., KAPOOR, N., ELDER, M., WARA, D., BOWEN, T., MADSEN, E., SNYDER, F.F., BASTIAN, J., MUUL, L., BLAESE, R.M., WEINBERG, K., and PARKMAN, R. (1998b). T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nature Med. 4, 775-780.
49. LAROCHELLE, A., VORMOOR, J., HANENBERG, H., WANG, J.C., BHATIA, M., LAPIDOT, T., MORITZ, T., MURDOCH, B., XIAO, X.L., KATO, I., WILLIAMS, D.A., and DICK, J.E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med. 2, 1329-1337.
50. LEBOULCH, P., HUANG, G.M., HUMPHRIES, R.K., OH, Y.H., EAVES, C.J., TUAN, D.Y., and LONDON, I.M. (1994). Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 13, 3065-3076.
51. LUSKEY, B.D., ROSENBLATT, M., ZSEBO, K., and WILLIAMS, D.A. (1992). Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80, 396-402.
52. MARDINEY, M.R., JACKSON, S.H., SPRATT, S.K., LI, F., HOLLAND, S.M., and MALECH, H.L. (1997). Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood. 89, 2268-2275.
53. MILLER, A.D. (1992). Retroviral vectors. Curr. Top. Microbiol. Immunol. 158, 1-24.
54. MILLER, A.D., GARCIA, J.V., von SUHR, N., LYNCH, C.M., WILSON, C., and EIDEN, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
55. MILLER, N., and WHELAN, J. (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8, 803-815.
56. MOORE, K.A., DEISSEROTH, A.B., READING, C.L., WILLIAMS, D.E., and BELMONT, J.W. (1992). Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79, 1393-1399.
57. MOREL, F., GALY, A., CHEN, B., and SZILVASSY, S.J. (1998). Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34-fractions of Thy-llowLin-/lowSca-1 + bone marrow cells. Exp. Hematol. 26, 440-448.
58. NAFFAKH, N., PINSET, C., MONTARRAS, D., LI, Z., PAULIN, D., DANOS, O., and HEARD, J.M. (1996). Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum. Gene Ther. 7, 11-21.
59. NALDINI, L. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457-463.
60. NALDINI, L., BLÖMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996a). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. [See comments]
61. NALDINI, L., BLÖMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996b). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
62. NATHWANI, A., PERSONS, D., STEVENSON, S., FRARE, P., McCLELLAND, A., NEINHUIS, A., and VANIN, E. (1999). Adenovirus-mediated expression of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. Gene Ther. 6, 1456-1468.
63. NEERING S.J., HARDY, S.F., MINAMOTO, D., SPRATT, S.K., and JORDAN, C.T. (1996). Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 88, 1147-1155.
64. NOLTA, J.A., and KOHN, D.B. (1990). Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum. Gene Ther. 1, 257-268.
65. NOLTA, J.A., CROOKS, G.M., OVERELL, R.W., WILLIAMS, D.E., and KOHN, D.B. (1992). Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines. Exp. Hematol. 20, 1065-1071.
66. NOVAK, U., HARRIS, E.A., FORRESTER, W., GROUDINE, M., and GELINAS, R. (1990). High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3386-3390.
67. OGAWA, M. (1993). Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844-2853.
68. ORLIC, D., and BODINE, D.M. (1994). What defines a pluripotent hematopoietic stem cell (PHSC): Will the real PHSC please stand up! Blood 84, 3991-3994.
69. ORLIC, D., GIRARD, L.J., IORDAN, C.T., ANDERSON, S.M., CLINE, A.P., and BODINE, D.M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 11097-11102.
70. ORLIC, D., GIRARD, L.J., ANDERSON, S.M., and BODINE, D.M. (1999). Retrovirus receptor mRNA expression correlates with gene transfer efficiency in pluripotent hematopoietic stem cells. Leukemia Suppl 1, S52-S54.
71. OSAWA, M., HANADA, K., HAMADA, H., and NAKAUCHI, H. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245.
72. PARKMAN, R. (1986). The application of bone marrow transplantation to the treatment of genetic disease. Science 232, 1373-1378.
73. PIACIBELLO, W., SANAVIO, F., GARETTO, L., SEVERINO, A., BERGANDI, D., FERRARIO, J., FAGIOLI, F., BERGER, M., and AGLIETTA, M. (1997). Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89, 2644-2653.
74. RIVELLA, S., and SADELAIN, M. (1998). Genetic treatment of severe hemoglobinopathies: The combat against transgene variegation and transgene silencing. Semin. Hematol. 35, 112-125.
75. RIVIÈRE, I., BROSE, K., and MULLIGAN, R.C. (1995). Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. U.S.A. 92, 6733-6737.
76. ROBBINS, P.B., SKELTON, D.C., YU, X.J., HALENE, S., LEONARD, E.H., and KOHN, D.B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 10182-10187.
77. ROSENZWEIG, M.., MAcVITTIE, T.J., HARPER, D., HEMPEL, D., GLICKMAN, R.L., JOHNSON, R.P., FARESE, A.M., WHITINGTHEOBALD, N., LINTON, G.F., YAMASAKI, G., JORDAN, C.T., and MALECH, H.L. (1999). Efficient and durable gene marking of hematopoietic progenitors cells in nonhuman primates after nonablative conditioning. Blood 94, 2271-2286.
78. RUSSEL, D.W., and KAY, M.A. (1999). Adeno-associated virus vectors and hematology. Blood 94, 864-874.
79. SADELAIN, M., WANG, C.H., ANTONIOU, M., GROSVELD, R., and MULLIGAN, R.C. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl. Acad. Sci. U.S.A. 92, 6728-6732.
80. SATO, T., LAVER, J., and OGAWA, M. (1999). Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94, 2548-2554.
81. SNYDER, R.O., MIAO, C., MEUSE, L., TUBB, J., DONAHUE, B.A., LIN, H.F., STAFFORD, D.W., PATEL, S., THOMPSON, A.R., NICHOLS, T., READ, M.S., BELLINGER, D.A., BRINKHOUS, K.M., and KAY, M.A. (1999). Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nature Med. 5, 64-70. [See comments]
82. STORB, R., YU, C., ZAUCHA, J.M., DEEG, H.J., GEORGES, G., KIEM, H.P., NASH, R.A., McSWEENEY, P.A., and WAGNER, J.L. (1999). Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94, 2523-2529.
83. STRAUSS, L.C., TRISCHMANN, T.M., ROWLEY, S.D., WILEY, J.M., and CIVIN, C.I. (1991). Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am. J. Pediatr. Hematol. Oncol. 13, 217-221.
84. SUTTON, R.E., WU, H.T., RIGG, R., BÖHNLEIN, E., and BROWN, P.O. (1998). Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72, 5781-5788.
85. SYKES, M., SACHS, D.H., NIENHUIS, A.W., PEARSON, D.A., MOULTON, A.D., and BODINE, D.M. (1993). Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55, 197-202.
86. TISDALE, J.F., HANAZONO, Y., SELLERS, S.E., AGRICOLA, B.A., METZGER, M.E., DONAHUE, R.E., and DUNBAR, C.E. (1998). Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92, 1131-1141.
87. TSUKIYAMA, T., NIWA, O., and YOKORO, K. (1989). Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol. Cell. Biol. 9, 4670-4676.
88. UCHIDA, N., SUTTON, R.E., FRIERA, A.M., HE, D., REITSMA, M.J., CHANG, W.C., VERES, G., SCOLLAY, R., and WEISSMAN, I.L. (1998). HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 11939-11944.
89. VAN BEUSECHEM, V.W., KUKLER, A., HEIDT, P.J., and VALERIO, D. (1992). Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone marrow cells. Proc. Natl. Acad. Sci. U.S.A. 89, 7640-7644.
90. WEISSMAN, I.L. (2000). Stem cells: Units of development, units of regeneration, and units in evolution. Cell 100, 157-168.
91. WELLS, S., MALIK, P., PENSIERO, M., KOHN, D.B., and NOLTA, J.A. (1995). The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Gene Ther. 2, 512-520.
92. WOLFE, J.H., SAND, M.S., BARKER, J.E., GWYNN, B., ROWE, L.B., VOGLER, C.A., and BIRKENMEIER, E.H. (1992). Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature (London) 360, 749-753.
93. YEE, J.K., MOORES, J.C., JOLLY, D.J., WOLFF, J.A., RESPRESS, J.G., and FRIEDMANN, T. (1987). Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. U.S.A. 84, 5197-5201.
94. YU, S.F., VON RÜDEN, T., KANTOFF, P.W., GARBER, C., SEIBERG, M., RÜTHER, U., ANDERSON, W.F., WAGNER, E.F., and GILBOA, E. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 83, 3194-3198.
95. ZANJANI, E.D., and ANDERSON, W.F. (1999). Prospects for in utero human gene therapy. Science 285, 2084-2088.
96. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875.
97. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.